Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2024; 70(1): 52-59


M. Khetsuriani, T.I. Drevytska, A.M. Shysh

    Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine


Long non-coding RNAs (lncRNAs) are the most numerous group of transcripts performing various functions, including the development of cardiovascular pathologies. We investigated the changes in expression of four long non-coding RNAs (H19, TUG1, GAS5, MIAT) under conditions of anoxia-reoxygenation in neonatal rat cardiomyocyte culture and ischemia-reperfusion in adult Wistar rats. A significant decrease in the expression of all four long non-coding RNAs in cell culture under experimental conditions was established. The regime of prolonged anoxia-reoxygenation led to a sharp increase in the expression level of long non-coding RNA MIAT by twice, but compared to normoxia, these changes were not significant. After ischemia-reperfusion in rat myocardium, the content of long non-coding RNA TUG1 increased by 22 times, while the expression of H19 decreased by 3.79 times, and in rat plasma, the expression of long non-coding RNA MIAT increased by 3.79 times. The obtained results allow considering long non-coding RNAs H19 and TUG1 as potential targets in ischemic myocardial injury, and MIAT as a biomarker of cardiovascular pathologies.

Keywords: long non-coding RNAs; ischemia; heart; myocardium; cardiomyocyte; H19; MIAT; TUG1.


  1. Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr Pharm Res Pract. 2019 Feb 4;8:1-11. CrossRef PubMed PubMedCentral
  2. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-337.
  3. Murphy SL, Xu J, Konachek KD. Division of vital statistics: Deaths: Final data for 2010. Natl Vital Stat Rep. 2013;61:1-117.
  4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation. 2014;129:e28-92.
  5. Ibáñez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71. CrossRef PubMed
  6. Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Liu SH, Zhang L, Jia HM, Vinten-Johansen J, Zhao ZQ. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol. 2007 Oct;19(10):424-30.
  7. M. Khetsuriani, V. Dosenko. Long non-coding RNAs as regulators of physiological and pathological processes of the cardiovascular system. Fiziol Zh. 2020; 66(4): 72-84. CrossRef
  8. Ma L, Cao J, Liu L, Du Q, Li Z, Zou D, Bajic VB, Zhang Z. LncBook: a curated knowledgebase of human long non-coding RNAs. Nucl Acids Res. 2019 Jan 8;47(D1):D128-34. CrossRef PubMed PubMedCentral
  9. Busscher D, Boon RA, Juni RP. The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases. Clin Sci (Lond). 2022 Aug 12;136(15):1157-78. CrossRef PubMed PubMedCentral
  10. Liu HL, Chen CH, Sun YJ. Overexpression of lncRNA GAS5 attenuates cardiac fibrosis through regulating PTEN/MMP-2 signal pathway in mice. Eur Rev Med Pharm Sci. 2019 May;23(10):4414-8.
  11. Wang YW, Dong HZ, Tan YX, Bao X, Su YM, Li X, Jiang F, Liang J, Huang ZC, Ren YL, Xu YL, Su Q. HIF1α-regulated lncRNA-TUG1 promotes mitochondrial dysfunction and pyroptosis by directly binding to FUS in myocardial infarction. Cell Death Disc. 2022 Apr 8;8(1):178. CrossRef PubMed PubMedCentral
  12. Yang C, Zhang Y, Yang B. MIAT, a potent CVD-promoting lncRNA. Cell Mol Life Sci. 2021 Dec 18;79(1):43. CrossRef PubMed
  13. Wang H, Lian X, Gao W, Gu J, Shi H, Ma Y, Li Y, Fan Y, Wang Q, Wang L. Long noncoding RNA H19 suppresses cardiac hypertrophy through the MicroRNA-145-3p/ SMAD4 axis. Bioengineered. 2022 Feb;13(2):3826-39. CrossRef PubMed PubMedCentral
  14. Gong LC, Xu HM, Guo GL, Zhang T, Shi JW, Chang C. Long non-coding RNA H19 protects H9c2 cells against hypoxia-induced injury by targeting microrna-139. Cell Physiol Biochem. 2017;44(3):857-69. CrossRef PubMed
  15. Zhang L, Liu T, Wang P, Shen Y, Huang T. Overexpression of long noncoding RNA H19 inhibits cardiomyocyte apoptosis in neonatal rats with hypoxic-ischemic brain damage through the miR-149-5p/LIF/PI3K/Akt axis. Biopreserv Biobank. 2021 Oct;19(5):376-85. CrossRef PubMed
  16. Su Q, Liu Y, Lv XW, Dai RX, Yang XH, Kong BH. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. Am J Physiol Heart Circ Physiol. 2020 Feb 1;318(2):H332-44. CrossRef PubMed
  17. Du J, Yang ST, Liu J, Zhang KX, Leng JY. Silence of LncRNA GAS5 protects cardiomyocytes H9c2 against hypoxic injury via sponging miR-142-5p. Mol Cells. 2019 May 31;42(5):397-405.
  18. Hao S, Liu X, Sui X, Pei Y, Liang Z, Zhou N. Long noncoding RNA GAS5 reduces cardiomyocyte apoptosis induced by MI through sema3a. Int J Biol Macromol. 2018 Dec;120(Part A):371-7. CrossRef PubMed
  19. Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, et al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci. 2019 Feb;76(3):441-51. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.